Biotechnology company Gelesis Holdings disclosed in a public filing that Elliot Maltz, chief financial officer, treasurer, chief compliance officer, and corporate secretary, resigned.

Gelesis said in the filing Yishai Zohar, president, chief executive, and member of the board of directors, will succeed Maltz as CCO, corporate secretary, treasurer, interim principal financial officer, and principal accounting officer.

Zohar, who has served as president and chief executive since January 2022, will continue in the role going forward, the company said. Prior to founding Gelesis, Zohar co-founded PureTech Health, which led to the formation of Gelesis.

Maltz resigned to serve as chief financial officer at biotechnology company Orgenesis, according to a post on his LinkedIn profile.